CJC-1295 (no DAC) 5MG
CJC-1295 (No DAC), also known as Modified GRF (1-29), is a synthetic growth hormone-releasing hormone (GHRH) analogue used in laboratory research. It is supplied as a white to off-white lyophilized powder, typically in a 5 mg vial, with high purity (≥98 % HPLC verified) and is intended strictly for research use only.
Unlike DAC-modified versions, CJC-1295 without DAC has a shorter half-life, making it useful for studying pulsatile growth hormone release and receptor activity in controlled preclinical and experimental settings.
CJC-1295 w/ DAC 5MG
CJC-1295 w/ DAC (5 mg) is a synthetic analogue of growth hormone-releasing hormone (GHRH) featuring a Drug Affinity Complex (DAC) that covalently binds serum albumin. This modification extends its half-life up to ~8 days, enabling prolonged and consistent GH release in research settings. It is supplied as a ≥98.5% pure, HPLC-verified lyophilized powder.
Mechanistically, CJC-1295 w/ DAC binds GHRH receptors on anterior pituitary somatotropic cells, activating a G-protein signaling cascade. This triggers adenylyl cyclase → cAMP → PKA activation, leading to CREB phosphorylation. Activated CREB drives GH gene transcription, supporting sustained GH and IGF-1 secretion studies.
DSIP 5MG
Delta Sleep-Inducing Peptide (DSIP) 5MG is a synthetic neuropeptide studied for its role in sleep regulation, particularly slow-wave (deep) sleep. It is supplied as a white to off-white lyophilized powder with ≥99% research-grade purity and a molecular formula of C₃₅H₄₈N₁₀O₁₅.
DSIP has been investigated for its involvement in promoting restorative sleep processes and neuroendocrine balance. Please note that only the 5MG strength is currently available, as the 10MG formulation is no longer being stocked.
Epitalon 10MG
Epithalon (Epitalon) is a high-purity (≥99%) synthetic tetrapeptide with the molecular formula C₁₄H₂₂N₄O₇, supplied as a white to off-white lyophilized powder in 10 mg research-grade quantities.
It is a synthetic derivative of epithalamin and has been studied for its potential role in modulating telomerase activity, with research suggesting an association with telomere elongation.
FOXO4-DRI
FOXO4-DRI (FOXO4 D-Retro-Inverso Peptide) is a synthetic research peptide composed of 27 D-amino acids with an approximate molecular weight of 5,350–5,400 Da and ≥99% purity. It is supplied as a white to off-white lyophilized powder in 5 mg or 10 mg quantities for laboratory research use.
Researchers use FOXO4-DRI to study cellular aging by examining the selective removal of senescent cells and its impact on tissue repair, regeneration, and longevity pathways through FOXO4–p53 interactions.
Fragment 176-191 5MG
HGH Fragment 176–191 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, consisting of 16 amino acids with a molecular weight of approximately 1,815 Da. It is supplied as a white to off-white lyophilized powder with ≥99% purity (HPLC, research grade) in 5 mg quantities.
Fragment 176–191 exhibits lipolytic and antilipogenic activity similar to that of the intact hormone. It is used in research settings to study mechanisms related to fat metabolism and metabolic activity.
GHK-CU 100MG
GHK-Cu (Copper Tripeptide-1) is a synthetic copper peptide complex composed of three amino acids (Gly–His–Lys) bound to copper (II), with a molecular weight of approximately 401.9 Da. It is supplied as a blue to blue-green lyophilized powder with ≥99% research-grade purity and a net content of 100 mg.
GHK-Cu is a naturally occurring copper polypeptide found in blood plasma and saliva and is provided strictly for research use only (RUO). It is not intended for human or veterinary use.
GHK-CU/BPC-157/TB-500 GLOW Blend
GLOW Blend (GHK-Cu, BPC-157, TB-500) is a research-grade peptide formulation containing ~70 mg per vial and verified at ≥99% purity. It is intended strictly for in-vitro and preclinical research and supplied as a lyophilized powder.
This synergistic blend supports advanced studies in tissue repair, epithelial cell health, collagen and elastin production, angiogenesis, and inflammation-related cellular pathways.
GHK-CU/BPC-157/TB-500/KPV KLOW Blend
KLOW Blend is a multi-component, research-grade peptide formulation combining GHK-Cu, BPC-157, TB-500, and KPV in a single lyophilized vial (~80 mg total). Designed for in-vitro and animal model research, it supports advanced investigation into tissue regeneration, inflammation modulation, and extracellular matrix signaling.
Each component contributes a complementary role in regenerative pathway studies, making KLOW Blend a versatile tool for laboratories conducting complex peptide and cellular research. For scientific research use only; not approved for human or veterinary application.
GHRP-6 5MG
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic met-enkephalin analog containing unnatural D-amino acids and composed of six amino acids, with a molecular weight of approximately 873.0 Da. It is classified as a synthetic growth hormone secretagogue (GHS) and is supplied as a white to off-white lyophilized powder with ≥99% HPLC research-grade purity in 5 mg quantities.
GHRP-6 functions as a hexapeptide ghrelin receptor agonist and is used exclusively for in vitro and laboratory research applications. It is intended for research use only (RUO), not for human or veterinary use, and should be stored at –20 °C or below while protected from light, heat, and moisture.
GLP-1SG 10MG
GLP-1SG (Glucagon-Like Peptide-1, Stabilized/Glycosylated or Super Gene variant) is a synthetic GLP-1–based peptide hormone analog consisting of approximately 30–31 amino acids, with a molecular weight of ~3,300–3,500 Da. It is supplied as a white to off-white lyophilized powder with ≥99% HPLC research-grade purity in 10 mg quantities.
GLP-1SG is designed to activate GLP-1 receptors and is modified for enhanced stability and resistance to enzymatic degradation. It is intended exclusively for in vitro and laboratory research use to support the study of metabolic pathways and is not for human or veterinary use.
GLP-2TZ
GLP-2TZ is a research-grade dual GLP-1/GIP agonist peptide designed to study combined incretin signaling.
It supports precise investigation of insulin release, fat metabolism, and energy homeostasis.
Select options
This product has multiple variants. The options may be chosen on the product page